[抗体作为特异性肿瘤治疗药物。是痴心妄想还是现实？] - Suppr

Suppr

超能文献

[Antibodies as specific tumor therapy agents. Wishful thinking or reality?].

作者信息

Gramatzki M, Valerius T

机构信息

Abteilung für Hämatologie/Onkologie, Medizinische Klinik III mit Poliklinik, Universität Erlangen-Nürnberg.

出版信息

Internist (Berl). 1997 Nov;38(11):1055-62. doi: 10.1007/s001080050117.

DOI:10.1007/s001080050117

PMID:9453954

Abstract

摘要

相似文献

[Antibodies as specific tumor therapy agents. Wishful thinking or reality?].

Internist (Berl). 1997 Nov;38(11):1055-62. doi: 10.1007/s001080050117.

The use of monoclonal antibody immunoconjugates in cancer therapy.

Adv Exp Med Biol. 1994;353:169-79. doi: 10.1007/978-1-4615-2443-4_16.

Improving the efficacy of antibody-based cancer therapies.

Nat Rev Cancer. 2001 Nov;1(2):118-29. doi: 10.1038/35101072.

Using antibodies to target cancer therapeutics.

Expert Opin Biol Ther. 2012 Sep;12(9):1173-90. doi: 10.1517/14712598.2012.693472. Epub 2012 Jun 1.

Concepts of antibody-mediated cancer therapy.

Cancer Invest. 1993;11(2):174-84. doi: 10.3109/07357909309024836.

Future prospects of monoclonal antibodies as magic bullets in immunotherapy.

Hum Antibodies. 2013;22(1-2):9-13. doi: 10.3233/HAB-130266.

Monoclonal antibody therapy of cancer.

Cancer Chemother Biol Response Modif. 1997;17:195-216.

Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

Adv Drug Deliv Rev. 2008 Sep;60(12):1407-20. doi: 10.1016/j.addr.2008.04.011. Epub 2008 Apr 24.

[Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].

Fortschr Med. 1994 Oct 20;112(29):399.

Progress in immunoconjugate cancer therapeutics.

Cancer Cell. 2003 Mar;3(3):207-12. doi: 10.1016/s1535-6108(03)00057-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Antibodies as specific tumor therapy agents. Wishful thinking or reality?].

Internist (Berl). 1997 Nov;38(11):1055-62. doi: 10.1007/s001080050117.

The use of monoclonal antibody immunoconjugates in cancer therapy.

Adv Exp Med Biol. 1994;353:169-79. doi: 10.1007/978-1-4615-2443-4_16.

Improving the efficacy of antibody-based cancer therapies.

Nat Rev Cancer. 2001 Nov;1(2):118-29. doi: 10.1038/35101072.

Using antibodies to target cancer therapeutics.

Expert Opin Biol Ther. 2012 Sep;12(9):1173-90. doi: 10.1517/14712598.2012.693472. Epub 2012 Jun 1.

Concepts of antibody-mediated cancer therapy.

Cancer Invest. 1993;11(2):174-84. doi: 10.3109/07357909309024836.

Future prospects of monoclonal antibodies as magic bullets in immunotherapy.

Hum Antibodies. 2013;22(1-2):9-13. doi: 10.3233/HAB-130266.

Monoclonal antibody therapy of cancer.

Cancer Chemother Biol Response Modif. 1997;17:195-216.

Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

Adv Drug Deliv Rev. 2008 Sep;60(12):1407-20. doi: 10.1016/j.addr.2008.04.011. Epub 2008 Apr 24.

[Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].

Fortschr Med. 1994 Oct 20;112(29):399.

Progress in immunoconjugate cancer therapeutics.

Cancer Cell. 2003 Mar;3(3):207-12. doi: 10.1016/s1535-6108(03)00057-6.